GE HealthCare Technologies Inc. Reports Climb In Q3 Bottom Line

What happened

GE HealthCare reported third-quarter earnings of $615 million, or $1.36 per share, up from $446 million, or $0.98 per share, a year earlier. Revenue rose 7.2% to $5.513 billion from $5.143 billion last year.

Confirmed

Global impact / market context

Higher profit and revenue show the company sold more equipment and services while keeping costs in check, which supports cash available for future capital spending, meaning money put into long-term assets. It also signals healthier demand from hospitals buying medical scanners and software.

Analyst inference

The results compare against a weaker quarter a year earlier, so the gain partly reflects an easier baseline. Full-year profit guidance of $4.95 to $5.05 per share and 2026 organic revenue growth guidance of 4.0%, which excludes currency swings, frame how investors judge the pace of future sales.

Analyst inference

What to watch

1. Watch whether full-year earnings per share land within the guided $4.95 to $5.05 range, since that range is the company's own stated outlook rather than a result already booked. Confirmed
2. Track whether 2026 organic revenue growth, which means sales growth excluding currency effects, reaches the guided 4.0%, because a shortfall would suggest weaker demand for scanners and related services. Proposed
3. Monitor whether rising revenue converts into cash available for capital spending and debt reduction, since profit growth alone does not show how much cash the business actually generates. Analyst inference

Evidence

• Original source link unavailable